Form D · Biotechnology

Ligandal Technology LLC

Oakland, CA · CIK 0001589489

Offering snapshot reported Jan 14, 2014 · SEC filing

Reported sold
$64K
Offering amount: $300K
Investors reported
3
Form D · investor count
Minimum accepted
$500
Reported outside-investor minimum
First sale
Oct 11, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$32K$64KOct 24, 2013: $20,000.00Oct 24, 2013Jan 14, 2014: $64,000.00Jan 14, 2014: $64,000.00Jan 14, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,000 → $64,000
  • Reported investors1 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 14, 2014Amendment$64,000$44,000vs Oct 24, 20133SEC filing
Jan 14, 2014Amendment$64,000$44,000vs Oct 24, 20133SEC filing
Oct 24, 2013Initial$20,000No comparison1SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-205212
Convertible Notes

Source: Form D, filed Jan 14, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alexander Honkala Executive
Patrick Nelson Executive
Edwin Urey Executive
Andre Watson Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1767 Indian Way
Oakland, CA, 94611